Prognostic Role of Osteopontin Expression in Malignant Pleural Mesothelioma

Authors:

Abstract
Malignant pleural mesothelioma (MPM) represents highly aggressive neoplasms with a mean survival of approximately 10 months. Osteopontin, a glycoprot